EP1311202A4
Method and system for anticoagulant dose revision
Abstract
This record has no abstract on file.
Term
Term ended
Projected expiry passed 13 August 2021, 5.1 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
2 sheets
Sheet 1 Sheet 2
Every citation, both waysCites: the store holds 1 of 2
| Document | Relation | Office | Cited during |
|---|---|---|---|
| WO0102050A2 | Cites | World Intellectual Property Organization (WIPO) | Examiner |
| ANSELL J ET AL: "Managing oral anticoagulant therapy.", CHEST JAN 2001, vol. 119, no. 1 Suppl, January 2001 (2001-01-01), pages 22S - 38S, XP002419348, ISSN: 0012-3692 | Non-patent | – | Search report |
| POLLER ET AL: "Multicentre randomised study of computerised anticoagluant dosage", THE LANCET, vol. 352, pages 1505 - 1509, XP004265723 | Non-patent | – | Examiner |
| See also references of WO 0219935A1 | Non-patent | – | Examiner |
58 members in 16 offices
Priority claims12
| Document | Office | Kind | Date |
|---|---|---|---|
| 644503 | United States of America | – | |
| 64450300 | United States of America | A | |
| 64450300 | United States of America | A | |
| 0125362 | United States of America | W | |
| 0125362 | United States of America | W | |
| 2401913 | Canada | A | |
| 2401913 | Canada | A | |
| 644503 | – | – | – |
| CA20022401913 | – | – | – |
| US20000644503 | – | – | – |
| US2001025362 | – | – | – |
| WO2001US25362 | – | – | – |
Members58
| Document | Office | Kind | |
|---|---|---|---|
| CA2362429A1 | Canada | A1 | |
| WO0102050A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU5919800A | Australia | A | |
| US6267116B1 | United States of America | B1 | |
| US2001018919A1 | United States of America | A1 | |
| US2001020475A1 | United States of America | A1 | |
| CA2404517A1 | Canada | A1 | |
| WO0174084A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU5121501A | Australia | A | |
| US2001042551A1 | United States of America | A1 | |
| US2001050920A1 | United States of America | A1 | |
| NO20020043D0 | Norway | D0 | |
| NO20020056D0 | Norway | D0 | |
| NO20020056L | Norway | L | |
| WO0102050A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0174084A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0174084B1 | World Intellectual Property Organization (WIPO) | B1 | |
| CA2419431A1 | Canada | A1 | |
| WO0219935A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU8486801A | Australia | A | |
| BR0012241A | Brazil | A | |
| EP1191894A2 | European Patent Office (EPO) | A2 | |
| KR20020036790A | Republic of Korea | A | |
| MXPA01013306A | Mexico | A | |
| CN1359276A | China | A | |
| IL147201A0 | Israel | A0 | |
| IL147201D0 | Israel | D0 | |
| TR2001003831T2 | Türkiye | T2 | |
| TR200103831T2 | Türkiye | T2 | |
| WO02082972A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO02082972A9 | World Intellectual Property Organization (WIPO) | A9 | |
| EP1273174A2 | European Patent Office (EPO) | A2 | |
| JP2003503165A | Japan | A | |
| CA2455455A1 | Canada | A1 | |
| WO03011215A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002322611A1 | Australia | A1 | |
| WO02082972A3 | World Intellectual Property Organization (WIPO) | A3 | |
| IL151950A0 | Israel | A0 | |
| IL151950D0 | Israel | D0 | |
| EP1311202A1 | European Patent Office (EPO) | A1 | |
| US6575169B2 | United States of America | B2 | |
| US6581606B2 | United States of America | B2 | |
| US6581607B2 | United States of America | B2 | |
| WO03011215A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CA2401913A1 | Canada | A1 | |
| NZ521644A | New Zealand | A | |
| EP1191894A4 | European Patent Office (EPO) | A4 | |
| CA2362429C | Canada | C | |
| AU2001251215B2 | Australia | B2 | |
| US6942614B1 | United States of America | B1 | |
| US7100193B2 | United States of America | B2 | |
| EP1311202A4This record | European Patent Office (EPO) | A4 | |
| EP1191894B1 | European Patent Office (EPO) | B1 | |
| AT378015T | Austria | T | |
| ATE378015T1 | Austria | T1 | |
| DE60037116D1 | Germany | D1 | |
| DE60037116T2 | Germany | T2 | |
| CA2455455C | Canada | C |
11 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Application refused18R | 18R | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION HAS BEEN REFUSEDSTAA | STAA | |
| First examination report despatched17Q | 17Q | |
| Supplementary search report drawn up and despatchedA4 | A4 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | |
| Request for examination filed17P | 17P | |
| Designated contracting statesAK | AK | |
| Request for extension of the european patentAX | AX | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI |
Numbers
- Publication
- 1311202
- Publication, DOCDB
- 1311202
- Publication, EPODOC
- EP1311202
- Application
- 1963959
- Application, DOCDB
- 01963959
- Application, EPODOC
- EP20010963959
Titles3
- German
- VERFAHREN UND VORRICHTUNG ZUR REVISION DER ANTIKOAGULANTDOSIS
- English
- METHOD AND SYSTEM FOR ANTICOAGULANT DOSE REVISION
- French
- PROCEDE ET SYSTEME DE REVISION DE DOSE D'ANTICOAGULANT
Classification
- CPC, 2
- A61B17/00
- A61P7/02
- IPC, 3
- A61B17 00
- A61K31 00
- A61P7 02
Designated states1
- Contracting states, 1
- Türkiye